Authorisations of human medicines

Within the framework of the authorisation procedure, Swissmedic assesses the quality, safety and effectiveness of the medicinal product in question on the basis of the comprehensive scientific documentation that is submitted.

If the criteria for authorisation are fulfilled, Swissmedic grants the marketing authorisation, specifies the method of sale (on prescription only/dispensing point) and approves the information for healthcare professionals and the patient information.

Informations

Show all

05.11.2025

Use of titanium dioxide in medicinal products

Titanium dioxide continues to be permitted as an excipient in medicinal products in Switzerland

01.11.2025

Modification of the information sheet Drug Safety Reporting Duties in Switzerland

Update of contact details and document links

01.10.2025

Changes to the Guidance document Meetings for applicants for authorisation procedures

Preliminary Decision Clarification Meeting for human medicinal products to be introduced